FGF21 and hydrops fetalis: In patients with HF, FGF21 was not associated with the rate of a composite of all-cause death or HF readmission, although this outcome should be considered with caution due to the substantial study heterogeneity and variability of effect sizes, including RR, univariate, and multivariate HR.